Publications by authors named "L Frankenstein"

Article Synopsis
  • Pulmonary lymphangiomatosis (PL) is an extremely rare lung disease marked by abnormal lymphatic growth, with no established diagnostic or treatment guidelines, prompting a study to gather patient data.
  • The study reviewed 12 patients diagnosed from 1996 to 2022, noting that most were younger women, non-smokers, and commonly experienced symptoms like difficulty breathing and coughing up blood or lymphatic fluid, with severe impacts on lung function.
  • Treatment with sirolimus resulted in significant improvements for patients, although further research is needed to fully understand the disease and develop comprehensive treatment strategies.
View Article and Find Full Text PDF

Si-based anodes can increase specific energy and energy density of Li ion batteries. However, the volume-induced material stress and capacity loss necessitates only a partial Si utilization within composite anodes, typically with state-of-the-art graphite, so called Si/Gr composites. In this work, various Si nanowires (SiNWs), a promising Si architecture for these composites, are investigated and modified via pre-lithiation.

View Article and Find Full Text PDF

Dual-ion batteries (DIBs) represent a promising alternative for lithium ion batteries (LIBs) for various niche applications. DIBs with polymer-based active materials, here poly(2,2,6,6-tetramethylpiperidinyl-N-oxyl methacrylate) (PTMA), are of particular interest for high power applications, though they require appropriate electrolyte formulations. As the anion mobility plays a crucial role in transport kinetics, Li salts are varied using the well-dissociating solvent γ-butyrolactone (GBL).

View Article and Find Full Text PDF
Article Synopsis
  • Patients with a history of prior myocardial infarction (pMI) have worse outcomes compared to those without pMI when dealing with ischaemic heart failure with reduced ejection fraction (HFrEF).
  • In a study involving 2,075 patients, it was found that those with pMI experienced higher all-cause mortality, greater event rates for death or shock from an ICD, and a more significant decline in mobility and overall health status after one year.
  • These findings suggest that patients with ischaemic HFrEF and a history of pMI are at a higher risk, indicating a need for more specialized care for this subgroup.
View Article and Find Full Text PDF

Background: Patients with chronic heart failure (CHF) frequently suffer from depressive comorbidity. CHF and depressive comorbidity can cause somatic symptoms. The correct attribution of somatic symptoms is important.

View Article and Find Full Text PDF